Related references
Note: Only part of the references are listed.Recent advances in mass spectrometry analysis of neuropeptides
Ashley Phetsanthad et al.
MASS SPECTROMETRY REVIEWS (2023)
In-Depth Site-Specific O-Glycosylation Analysis of Glycoproteins and Endogenous Peptides in Cerebrospinal Fluid (CSF) from Healthy Individuals, Mild Cognitive Impairment (MCI), and Alzheimer's Disease (AD) Patients
Zhengwei Chen et al.
ACS CHEMICAL BIOLOGY (2022)
Identification of tumor antigens with immunopeptidomics
Chloe Chong et al.
NATURE BIOTECHNOLOGY (2022)
A genetically encoded sensor for in vivo imaging of orexin neuropeptides
Loic Duffet et al.
NATURE METHODS (2022)
The role of neuropeptide somatostatin in the brain and its application in treating neurological disorders
You-Hyang Song et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2021)
Peptidomics: A Review of Clinical Applications and Methodologies
Rachel E. Foreman et al.
JOURNAL OF PROTEOME RESEARCH (2021)
The plasma peptides of Alzheimer's disease
Angelique Florentinus-Mefailoski et al.
CLINICAL PROTEOMICS (2021)
VGF as a biomarker and therapeutic target in neurodegenerative and psychiatric diseases
James P. Quinn et al.
BRAIN COMMUNICATIONS (2021)
Proteomics in cerebrospinal fluid and spinal cord suggests UCHL1, MAP2 and GPNMB as biomarkers and underpins importance of transcriptional pathways in amyotrophic lateral sclerosis
Patrick Deckl et al.
ACTA NEUROPATHOLOGICA (2020)
A New Serum Biomarker Set to Detect Mild Cognitive Impairment and Alzheimer's Disease by Peptidome Technology
Koji Abe et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Proteomics-Enriched Prediction Model for Poor Neurologic Outcome in Cardiac Arrest Survivors*
Klaus Distelmaier et al.
CRITICAL CARE MEDICINE (2020)
Functional Role of the Secretin/Secretin Receptor Signaling During Cholestatic Liver Injury
Nan Wu et al.
HEPATOLOGY (2020)
The Quest for the Best Dual Orexin Receptor Antagonist (Daridorexant) for the Treatment of Insomnia Disorders
Christoph Boss et al.
CHEMMEDCHEM (2020)
Carnosine in health and disease
Guilherme Giannini Artioli et al.
EUROPEAN JOURNAL OF SPORT SCIENCE (2019)
Synthetic standard aided quantification and structural characterization of amyloid-beta glycopeptides enriched from cerebrospinal fluid of Alzheimer's disease patients
Jonas Nilsson et al.
SCIENTIFIC REPORTS (2019)
The challenges of peptidomics in complementing proteomics in a clinical context
Evelyne Maes et al.
MASS SPECTROMETRY REVIEWS (2019)
Single-pot, solid-phase-enhanced sample preparation for proteomics experiments
Christopher S. Hughes et al.
NATURE PROTOCOLS (2019)
Improved LC-MS/MS method for the quantification of hepcidin-25 in clinical samples
Ioana M. Abbas et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2018)
Endogenous and Exogenous Opioids in Pain
Gregory Corder et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 41 (2018)
Digging Deep into Peptidomics Applied to Body Fluids
Rui Vitorino
PROTEOMICS (2018)
Are N- and C-terminally truncated A species key pathological triggers in Alzheimer's disease?
Julie Dunys et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Online Parallel Accumulation Serial Fragmentation (PASEF) with a Novel Trapped on Mobility Mass Spectrometer
Florian Meier et al.
MOLECULAR & CELLULAR PROTEOMICS (2018)
Changes of Cerebrospinal Fluid Peptides due to Tauopathy
Petra Majerova et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Multiplexed Temporal Quantification of the Exercise-regulated Plasma Peptidome
Benjamin L. Parker et al.
MOLECULAR & CELLULAR PROTEOMICS (2017)
Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer's disease
Yuki Kitamura et al.
NEUROLOGICAL RESEARCH (2017)
Expanding the cerebrospinal fluid endopeptidome
Karl T. Hansson et al.
PROTEOMICS (2017)
Alpha-, Beta-, and Gamma-synuclein Quantification in Cerebrospinal Fluid by Multiple Reaction Monitoring Reveals Increased Concentrations in Alzheimer's and Creutzfeldt-Jakob Disease but No Alteration in Synucleinopathies
Patrick Oeckl et al.
MOLECULAR & CELLULAR PROTEOMICS (2016)
Label-free quantitative comparison of cerebrospinal fluid glycoproteins and endogenous peptides in subjects with Alzheimer's disease, mild cognitive impairment, and healthy individuals
Jingxin Wang et al.
PROTEOMICS CLINICAL APPLICATIONS (2016)
A single dose of the γ-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humans
Mikko Holtta et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
The emerging role of the peptidome in biomarker discovery and degradome profiling
Zon W. Lai et al.
BIOLOGICAL CHEMISTRY (2015)
NeuroPep: a comprehensive resource of neuropeptides
Yan Wang et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2015)
An Integrated Workflow for Multiplex CSF Proteomics and Peptidomics-Identification of Candidate Cerebrospinal Fluid Biomarkers of Alzheimer's Disease
Mikko Holtta et al.
JOURNAL OF PROTEOME RESEARCH (2015)
PROINFLAMMATORY AND ANTIINFLAMMATORY ATTRIBUTES OF FETUIN-A: A NOVEL HEPATOKINE MODULATING CARDIOVASCULAR AND GLYCEMIC OUTCOMES IN METABOLIC SYNDROME
Satinath Mukhopadhyay et al.
ENDOCRINE PRACTICE (2014)
Roles of serum fibrinogen α chain-derived peptides in Alzheimer's disease
Miwa Noguchi et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2014)
A novel function for proSAAS as an amyloid anti-aggregant in Alzheimer's disease
Akina Hoshino et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Biomarkers in Amyloid-β Immunotherapy Trials in Alzheimer's Disease
Kaj Blennow et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Clinical Utility and Analytical Challenges in Measurement of Cerebrospinal Fluid Amyloid-β1-42 and τ Proteins as Alzheimer Disease Biomarkers
Ju-Hee Kang et al.
CLINICAL CHEMISTRY (2013)
Peptidomic discovery of short open reading frame-encoded peptides in human cells
Sarah A. Slavoff et al.
NATURE CHEMICAL BIOLOGY (2013)
A rapid MALDI-TOF mass spectrometry workflow for Drosophila melanogaster differential neuropeptidomics
Joseph P. Salisbury et al.
MOLECULAR BRAIN (2013)
Simultaneous determination and validated quantification of human insulin and its synthetic analogues in human blood serum by immunoaffinity purification and liquid chromatography-mass spectrometry
Cornelius Hess et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2012)
PEAKS DB: De Novo Sequencing Assisted Database Search for Sensitive and Accurate Peptide Identification
Jing Zhang et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
A novel peptidomics approach to detect markers of Alzheimer's disease in cerebrospinal fluid
Dorien Wijte et al.
METHODS (2012)
Peptidome Analysis of Cerebrospinal Fluid by LC-MALDI MS
Mikko Holtta et al.
PLOS ONE (2012)
Plasma Fetuin-A is Associated with the Severity of Cognitive Impairment in Mild-to-Moderate Alzheimer's Disease
Edward R. Smith et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment
Juergen Cox et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Mass Spectrometry-based Proteomics Using Q Exactive, a High-performance Benchtop Quadrupole Orbitrap Mass Spectrometer
Annette Michalski et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
Peptide Fingerprinting of Alzheimer's Disease in Cerebrospinal Fluid: Identification and Prospective Evaluation of New Synaptic Biomarkers
Holger Jahn et al.
PLOS ONE (2011)
Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid β-peptides in human cerebrospinal fluid
Adnan Halim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Skyline: an open source document editor for creating and analyzing targeted proteomics experiments
Brendan MacLean et al.
BIOINFORMATICS (2010)
Standardized peptidome profiling of human cerebrospinal fluid by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
Mathias Bruegel et al.
JOURNAL OF PROTEOMICS (2009)
Secretin as a neurohypophysial factor regulating body water homeostasis
Jessica Y. S. Chu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
BRI2 (ITM2b) inhibits Aβ deposition in vivo
Jungsu Kim et al.
JOURNAL OF NEUROSCIENCE (2008)
Integrated analysis of the cerebrospinal fluid peptidome and proteome
Alexandre Zougman et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Comparison of mascot and X!Tandem performance for low and high accuracy mass spectrometry and the development of an adjusted Mascot threshold
Markus Brosch et al.
MOLECULAR & CELLULAR PROTEOMICS (2008)
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
Juergen Cox et al.
NATURE BIOTECHNOLOGY (2008)
Endogeneous peptide profiling of cerebrospinal fluid by MALDI-TOF mass spectrometry: Optimization of magnetic bead-based peptide capture and analysis of preanalytical variables
Connie R. Jimenez et al.
PROTEOMICS CLINICAL APPLICATIONS (2007)
Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease
Erin J. Finehout et al.
ANNALS OF NEUROLOGY (2007)
Antimicrobial peptides derived from growth factors
Martin Malmsten et al.
GROWTH FACTORS (2007)
Early neuropathology of somatostatin/NPY GABAergic cells in the hippocampus of a PS1 x APP transgenic model of Alzheimer's disease
Blanca Ramos et al.
NEUROBIOLOGY OF AGING (2006)
Identification of novel biomarker candidates by differential peptidomics analysis of cerebrospinal fluid in Alzheimer's disease
H Selle et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2005)
High-throughput biomarker discovery and identification by mass spectrometry
C Menzel et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2005)
Truncated cystatin C in cerebrospiral fluid: Technical artefact or biological process?
O Carrette et al.
PROTEOMICS (2005)
Translocation of dynorphin neuropeptides across the plasma membrane -: A putative mechanism of signal transmission
Z Marinova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Proteomics analysis of human cerebrospinal fluid
XL Yuan et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2005)
Human cerebrospinal fluid peptidomics
XL Yuan et al.
JOURNAL OF MASS SPECTROMETRY (2005)
Top-down identification of endogenous peptides up to 9 kDa in cerebrospinal fluid and brain tissue by nanoelectrospray quadrupole time-of-flight tandem mass spectrometry
T Möhring et al.
JOURNAL OF MASS SPECTROMETRY (2005)
Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease
M Puchades et al.
MOLECULAR BRAIN RESEARCH (2003)
A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease
O Carrette et al.
PROTEOMICS (2003)
Mass spectrometry-based proteomics
R Aebersold et al.
NATURE (2003)
PEAKS: powerful software for peptide de novo sequencing by tandem mass spectrometry
B Ma et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2003)
High-resolution peptide mapping of cerebrospinal fluid:: a novel concept for diagnosis and research in central nervous system diseases
G Heine et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2002)
Region-specific reduction of Aβ-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging
N Iwata et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
The human plasma proteome - History, character, and diagnostic prospects
NL Anderson et al.
MOLECULAR & CELLULAR PROTEOMICS (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Peptide repertoire of human cerebrospinal fluid:: novel proteolytic fragments of neuroendocrine proteins
M Stark et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2001)
VGF: A novel role for this neuronal and neuroendocrine polypeptide in the regulation of energy balance
SRJ Salton et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2000)
Subtilase-like pro-protein convertases: from molecular specificity to therapeutic applications
F Bergeron et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2000)
Share Paper
